XENTIVA Trademark

Trademark Overview


On Monday, April 1, 2002, a trademark application was filed for XENTIVA with the United States Patent and Trademark Office. The USPTO has given the XENTIVA trademark a serial number of 76389448. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Saturday, December 4, 2004. This trademark is owned by Eli Lilly and Company. The XENTIVA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous systems diseases and disorders, dermatological disorders, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders
xentiva

General Information


Serial Number76389448
Word MarkXENTIVA
Filing DateMonday, April 1, 2002
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSaturday, December 4, 2004
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 11, 2003

Trademark Statements


Goods and Servicespharmaceutical preparations, namely pharmaceutical preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous systems diseases and disorders, dermatological disorders, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 8, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Wednesday, March 9, 2005ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, March 9, 2005ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 1, 2004EXTENSION 2 GRANTED
Thursday, April 1, 2004EXTENSION 2 FILED
Friday, April 9, 2004CASE FILE IN TICRS
Thursday, April 1, 2004TEAS EXTENSION RECEIVED
Monday, October 27, 2003EXTENSION 1 GRANTED
Monday, October 20, 2003EXTENSION 1 FILED
Monday, October 20, 2003TEAS EXTENSION RECEIVED
Tuesday, June 3, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 11, 2003PUBLISHED FOR OPPOSITION
Wednesday, February 19, 2003NOTICE OF PUBLICATION
Monday, January 13, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 13, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 26, 2002ASSIGNED TO EXAMINER
Friday, December 13, 2002PAPER RECEIVED
Monday, August 12, 2002LETTER OF SUSPENSION MAILED
Monday, July 29, 2002ASSIGNED TO EXAMINER
Friday, July 26, 2002ASSIGNED TO EXAMINER